secwatch.observer — SEC 8-K summary
======================================

Issuer:     NexImmune, Inc. (—)
CIK:        0001538210
Form:       8-K
Filed at:   2024-08-27T23:59:59+00:00
Accession:  0001193125-24-207749
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

NexImmune appoints wind-down officer; all directors and execs resign after shareholder-approved dissolution
--------------------------------------------------------------------------------

- All eight directors, including CEO Kristi Jones, CSO Mathias Oelke, and interim CFO Albert Marchio, resigned effective Aug 27, 2024.
- Craig Jalbert appointed as sole director, President, Treasurer, Corporate Secretary, and principal executive/financial officer effective Aug 27.
- Jalbert to receive $50,000/year for three years for winding down the company.
- Board approved filing certificate of dissolution with Delaware Secretary of State upon completion of wind-down.
- Company cautions trading in NEXI stock is highly speculative; urges extreme caution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/d890897d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-207749

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer